ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.

Niannian Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.